Table 2.
Relevant data of patients based on their micronutrient levels.
| VIT.A (mg/L) |
VIT. B6 (ng/mL) |
VIT.C (mcg/dL) |
VIT.D (ng/mL) |
VIT.E (mg/L) |
ZINC (µg/dL) |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory reference values | Normal [0.3–0.6] | Low [<0.3] |
Normal [3.6–18] | Low [<3.6] |
Normal [0.4–2] | Low [<0.4] |
Normal [20–150] | Low [<20] |
Normal [5–18] | Low [<5] |
Normal [84–159] | Low [<84] |
| Number of patients 1, n (%) | 34 (28.3) |
86 (71.7) | 69 (57.5) | 51 (42.5) |
0 | 55 (100) | 27 (25.7) |
78 (74.3) | 113 (94.2) | 7 (5.8) |
31 (25.8) |
89 (74.2) |
| Sex (male), n (%) | 13 (44.8) |
60 * (69) |
43 (68.3) | 30 (57.7) |
5 (71.4) |
36 (75) |
40 (57.1) |
25 (71.4) | 71 (62.8) |
6 (85.7) | 19 (61.3) |
58 (65.2) |
| Age (years), mean (SD) | 57.8 (13.4) | 63 (13.3) | 60.1 (14) | 63.6 (12.9) | 58.6 (7.3) |
59.1 (12.1) | 63.1 (13.7) | 59.7 (13.7) | 61.5 (13.3) | 61.3 (16) | 56.5 (13) |
63.2 * (13.2) |
| Mortality, n (%) | 5 (17.2) |
25 (29.4) | 10 (16.1) | 17 (33.3) |
2 (28.6) |
15 (31.9) | 7 (28) |
11 (31.4) | 28 (25.7) |
2 (28.6) | 5 (16.1) |
26 (29.9) |
| ICU, n (%) admission |
6 (20.7) |
54 * (62.1) | 38 (60.3) | 22 (42.3) |
7 (100) |
48 (100) | 15 (55.6) |
18 (51.4) | 58 (52.3) |
5 (71.4) | 9 (29) |
55 * (61.8) |
| NAD, n (%) |
3 (7.1) |
39 * (92.9) | 26 (56.5) | 16 (34.8) |
6 (15%) |
34 (85%) | 9 (25%) |
17 (47.2) | 41 (89.1) |
4 (8.7) |
5 (10.9) |
41 * (89.1) |
| DBT, n (%) | 1 (16.7) |
5 (83.3) | 3 (42.9) |
3 (42.9) |
1 (16.7) |
5 (83.3) | 1 (25) |
3 (75) |
6 (85.7) |
1 (14.3) | 0 | 7 (100) |
| DVT, n (%) | 1 (12.5) |
7 (87.5) |
5 (55.6) |
3 (33.3) |
3 (60) |
2 (40) |
2 (25) |
4 (50) |
8 (88.9) |
1 (11.1) | 2 (22.2) |
7 (77.8) |
| PE, n (%) | 0 | 4 (100) |
1 (25) |
2 (50) |
1 (33.3) |
2 (66.7) | 1 (50) |
1 (50) |
3 (75) |
1 (25) |
1 (25) |
3 (75) |
| HF, n (%) | 1 (20%) |
4 (80) |
2 (40) |
2 (40) |
1 (20) |
4 (80) |
0 | 2 (100) |
4 (80) |
1 (20) |
1 (20) |
4 (80) |
| AKI, n (%) | 5 (17.2) |
24 (82.8) | 19 (61.3) | 9 (29) |
4 (18.2) |
18 (81.8) | 6 (22.2) |
11 (40.7) | 28 (90.3) |
2 (6.5) |
6 (19.4) |
25 (80.6) |
| ID, n (%) | 0 | 3 (100) |
2 (50) |
2 (50) |
1 (50) |
1 (50) |
0 | 3 * (100) | 4 (100) |
0 | 0 | 4 (100) |
| CRRT, n (%) |
0 | 4 (100) |
1 (25) |
1 (25) |
1 (33.3) |
2 (66.7) | 0 | 2 (100) |
3 (75) |
1 (25) |
0 | 4 (100) |
| OTI, n (%) | 4 (7.7) |
48 * (92.3) | 34 (60.7) | 18 (32.1) |
7 (14.3) |
42 (85.7) | 11 (26.2) |
17 (40.5) | 51 (91.1) |
4 (7.1) |
7 (12.5) |
49 * (87.5) |
| PP, n (%) | 3 (6.4) |
44 * (93.6) | 29 (58) |
18 (36) |
7 (17.5) |
33 (82.5) | 12 (28.6) |
17 (40.5) | 45 (90) |
4 (8) |
7 (14) |
43 * (86) |
| BRS, n (%) | 2 (7.4) |
25 * (92.6) | 18 (60) |
11 (36.7) |
4 (17.4) |
19 (82.6) | 5 (23.8) |
8 (38.1) | 29 (96.7) |
1 (3.3) |
3 (10) |
27 * (90) |
1 Number of patients means the number of patients with normal or low values of the micronutrient. AKI: Acute Kidney Injury; BRS: Bacterial Respiratory Superinfection; CRRT: Continuous Renal Replacement Therapy; DBT: Dobutamine; DVT: Deep Venous Thrombosis; HF: Heart Failure; ID: Intermittent Dialysis; IL(6): Interleukin-6; NAD: Noradrenaline; OTI: Orotracheal Intubation; PE: Pulmonary Embolism; PP: Prone Position. * p < 0.05.